Patient Safety
Quality Resources
Discover more efficient office practices and risk management strategies for increasing your patients' safety.
FDA and CDC notifications
Recent drug and device alerts
- FDA safety communication: Update on the safety of Andexxa by AstraZeneca
- FDA and CDC recommend pause in use of Ixchiq (chikungunya vaccine, live) in individuals 60 years of age and older while postmarketing safety reports are investigated
- Medtronic Neurosurgery issues correction for Becker and Exacta External Drainage and Monitoring Systems due to cracks and/or leaks in stopcocks
- FDA adds boxed warning about a rare but serious allergic reaction called anaphylaxis with the multiple sclerosis medicine glatiramer acetate (Copaxone, Glatopa)
- Biopsy needle recall: Elekta removes disposable biopsy needle kits due to risk of microscopic stainless steel debris inside needle
Abuse and violence
Screening for abuse and violence in patients with neurological conditions is important. The American Academy of Neurology retired the 2012 abuse and violence position statement to allow flexibility in meeting individual provider needs and promotion of resources in this rapidly changing landscape. The following resources are provided to help you identify the appropriate screening method and frequency for your patient population:
- For Survivors of Intimate Partner Violence, Overlooked Brain Injuries Take a Toll
- Partner Violence and Abuse of Elderly and Vulnerable Adults: Screening
- American Academy of Family Physicians Detecting Elder Abuse and Neglect: Assessment and Intervention
- AMA Preventing, Identifying & Treating Violence & Abuse
- American Academy of Family Physicians Intimate Partner Violence
- American Academy of Pediatrics Council on Child Abuse and Neglect
Older driver safety
- The Physician's Guide to Assessing and Counseling Older Drivers from the American Medical Association, in collaboration with the National Highway Traffic Safety Administration.
- AAN's Guideline for the Assessment of Driving Risk in Patients with Dementia
- AAN's quality measure for Driving Screening and Follow-Up for Patients with Dementia